The Zhitong Finance App learned that according to the latest data from the Hong Kong Stock Exchange, on August 7, Junshengtai Pharmaceutical-B (02511) had a position change, with a total market value of HK$287 million, accounting for 14.73%. The company's shareholders deposited 52.601 million shares in CITIC Securities Brokerage Hong Kong, increasing their shareholding ratio by 5.57%.

According to Junshengtai Pharmaceutical's results for the year ended December 31, 2025, the group obtained additional revenue of 19.07 million yuan, a year-on-year decrease of 72.04%; the company's owners should have accounted for a loss of 245 million yuan, a year-on-year decrease of 35.84%; and a loss of 0.51 yuan per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.